• FirefoxInstall the new Firefox »
  •  Dow Down0.43% Nasdaq Down0.53%

    United Therapeutics Corporation (UTHR)

    157.22 Up 1.80(1.16%) 3:35PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.6
    Mean Recommendation (last week):2.6

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:150.60
    Median Target:150.00
    High Target:195.00
    Low Target:89.00
    No. of Brokers:15

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Nov 3, 2014ArgusDowngradeBuyHold
    Oct 15, 2014Standpoint ResearchUpgradeHoldBuy
    Apr 7, 2014Standpoint ResearchUpgradeHoldBuy
    Dec 23, 2013Ladenburg ThalmannUpgradeNeutralBuy
    Jul 30, 2013Standpoint ResearchDowngradeBuyHold
    Jun 20, 2013Standpoint ResearchUpgradeHoldBuy
    May 15, 2013Standpoint ResearchDowngradeBuyHold
    Aug 3, 2012Standpoint ResearchDowngradeBuyHold
    Apr 27, 2012Canaccord GenuityDowngradeBuyHold
    Mar 26, 2012Canaccord GenuityInitiated Buy

    More Upgrades & Downgrades for UTHR

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy2222

    Data provided by Thomson/First Call

    Currency in USD.